{
    "code": "01R00012",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01R00012",
    "time": "2016-03-25 04:17:15",
    "許可證字號": "衛署藥製字第R00012號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/07\/12",
    "發證日期": "85\/07\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY001R0001205",
    "中文品名": "核研氯化亞鉈（鉈－２０１）注射劑",
    "英文品名": "INER THALLOUS CHLORIDE(T1-201)INJECTION",
    "適應症": "心肌灌注造影（用以診斷冠狀動脈疾病、急性心肌梗塞和冠狀動脈繞道移植的手術後評估）",
    "劑型": "270注射劑",
    "包裝": "1ML,2ML,3ML,4ML,5ML,小瓶 6ML小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "THALLIUM TL-201",
    "限制項目": [
        "01國產",
        "05限供軍用"
    ],
    "申請商名稱": "0613004200  行政院原子能委員會核能研究所",
    "申請商地址": "桃園市龍潭區三號信箱",
    "主製造廠": {
        "製造廠名稱": "0613004300  行政院原子能委員會核能研究所",
        "製造廠廠址": "桃園市龍潭區佳安村文化路１０００號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30063000002 Ｘ光檢驗用不透光製劑；專供病人用之診斷用試藥Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7804000800",
            "成分名稱": "THALLIUM TL-201",
            "含量描述": "59.2",
            "含量": "59.2000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "1.Tl-201仿單-104-10-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01R00012&Seq=001&Type=9"
        },
        {
            "title": "1.Tl-201瓶標-104-10-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01R00012&Seq=001&Type=8"
        }
    ]
}